VELCADE® Treatment Approaches

This report compiles notes from roundtable meeting of members of the International Myeloma Foundation (IMF) Nurse Leadership Board who convened at the December 6th American Society of Hematology (ASH) Annual Meeting. They discussed treatment best practices for using VELCADE® in multiple myeloma (MM) patients.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.